Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gram Negative Meningitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04665791
What this trial is testing

A Human Controlled Infection Study with Neisseria Lactamica in Malian Adults

Who this might be right for
Meningitis, Meningococcal
Center for Vaccine Development - Mali 55
Not applicableStudy completedNCT01452438
What this trial is testing

Safety Surveillance of MenACWY-CRM Vaccine in Children

Who this might be right for
Meningococcal Disease
Novartis Vaccines 393
Post-approval studies (Phase 4)Study completedNCT00581035
What this trial is testing

Study Evaluating the Safety and Ability to Produce Immune Response of Prevenar and Meningitec Given at the Same Time

Who this might be right for
Healthy
Wyeth is now a wholly owned subsidiary of Pfizer 712
Large-scale testing (Phase 3)Study completedNCT04707391
What this trial is testing

Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine

Who this might be right for
Meningitis, Meningococcal
GlaxoSmithKline 1,250
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Testing effectiveness (Phase 2)Study completedNCT00937521
What this trial is testing

Safety and Immunogenicity in Dose-Ranging and Formulation-Finding Meningococcal B (MenB) Vaccine Study in 2-month-old Infants

Who this might be right for
Meningococcal MeningitisMeningococcal Infections
Novartis Vaccines 1,507
Large-scale testing (Phase 3)Study completedNCT00443846
What this trial is testing

RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016)

Who this might be right for
Meningitis, MeningococcalRotavirus Infections
Merck Sharp & Dohme LLC 247
Post-approval studies (Phase 4)Study completedNCT01659996
What this trial is testing

Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age

Who this might be right for
MeningitisMeningococcal InfectionDiphtheria+3 more
Sanofi Pasteur, a Sanofi Company 1,394
Large-scale testing (Phase 3)Study completedNCT03621670
What this trial is testing

Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 1,196
Post-approval studies (Phase 4)UnknownNCT03682939
What this trial is testing

Evaluation of Safety and Immunogenicity of Meningococcal B and Meningococcal ACWY Vaccine in at Risk Population

Who this might be right for
HivMeningitis, MeningococcalHIV Infections
St George's, University of London 55
Testing effectiveness (Phase 2)Study completedNCT02237365
What this trial is testing

A Pilot Study of Adjunctive Aspirin for the Treatment of HIV Negative Adults With Tuberculous Meningitis

Who this might be right for
Tuberculous Meningitis
Oxford University Clinical Research Unit, Vietnam 120
Post-approval studies (Phase 4)Study completedNCT00777257
What this trial is testing

Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine

Who this might be right for
MeningitisMeningococcemiaPertussis+2 more
Sanofi Pasteur, a Sanofi Company 1,345
Post-approval studies (Phase 4)Study completedNCT03493919
What this trial is testing

A Sourcing Study to Collect Human Blood Samples From Healthy Adults

Who this might be right for
Meningitis, Meningococcal
GlaxoSmithKline 1,021
Large-scale testing (Phase 3)Study completedNCT02274285
What this trial is testing

DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants

Who this might be right for
TetanusDiphtheriaPertussis+2 more
Sanofi Pasteur, a Sanofi Company 424
Large-scale testing (Phase 3)Study completedNCT03205371
What this trial is testing

Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers

Who this might be right for
Meningitis, Meningococcal
Sanofi Pasteur, a Sanofi Company 1,183
Large-scale testing (Phase 3)Study completedNCT00944034
What this trial is testing

Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered as Booster Dose at 12, 18 or 24 Months of Age in Toddlers (12-24 Months) Primed With a Three-Dose Immunization Series as Infants in Study V72P12

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 1,588
Large-scale testing (Phase 3)UnknownNCT04689165
What this trial is testing

A Phase III Clinical Trial of the Group A Meningococcal Polysaccharide Vaccine

Who this might be right for
Meningitis, Meningococcal
Wei Cun 1,280
Early research (Phase 1)Study completedNCT00631995
What this trial is testing

Safety and Immunogenicity of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Toddlers

Who this might be right for
MeningitisMeningococcal Infection
Sanofi Pasteur, a Sanofi Company 360
Large-scale testing (Phase 3)Study completedNCT01214837
What this trial is testing

Safety and Immunogenicity of 2 or 3 Doses of MenACWY Conjugate Vaccine in Healthy Infants and the Effects of a Booster Dose of MenACWY Administered in the Second Year of Life

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 751
Testing effectiveness (Phase 2)UnknownNCT02919293
What this trial is testing

Immunogenicity and Safety of Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine in Infants 2 to 5 Months of Age

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 360
Next Page